BeyondSpring (BYSI) vs Seres Therapeutics (MCRB)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Seres Therapeutics is the larger company by market cap ($26.5 million vs $25.8 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | BYSI | MCRB |
|---|---|---|
| Share price | $0.6276 | $2.64 |
| Market cap | $25.81M | $26.52M |
| 1-day change | -2.70% | -2.94% |
| YTD return | -60.46% | — |
| 1-year return | -64.09% | — |
| 5-year return | -96.11% | — |
| EPS (TTM) | $-0.18 | $-2.42 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $2.44 | $29.98 |
| 52-week low | $0.566 | $2.61 |
| Distance from 52-week high | -74.28% | -91.19% |
| Average volume | 855.49K | 72.00K |
| Shares outstanding | 41.12M | 10.04M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
BYSI vs MCRB FAQ
Which is bigger, BeyondSpring or Seres Therapeutics?
Seres Therapeutics (MCRB) is larger, with a market capitalization of $26.52M compared with $25.81M for BeyondSpring (BYSI).
Are BeyondSpring and Seres Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.